Cargando…
Fibrin-mediated Protection Against Infection-stimulated Immunopathology
Fibrin, a product of the blood coagulation cascade, accompanies many type 1 immune responses, including delayed-type hypersensitivity, autoimmunity, and graft rejection. In those settings, fibrin is thought to exacerbate inflammation and disease. Here, we evaluate roles for coagulation during infect...
Autores principales: | , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
The Rockefeller University Press
2003
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2193855/ https://www.ncbi.nlm.nih.gov/pubmed/12629066 http://dx.doi.org/10.1084/jem.20021493 |
_version_ | 1782147567987982336 |
---|---|
author | Johnson, Lawrence L. Berggren, Kiera N. Szaba, Frank M. Chen, Wangxue Smiley, Stephen T. |
author_facet | Johnson, Lawrence L. Berggren, Kiera N. Szaba, Frank M. Chen, Wangxue Smiley, Stephen T. |
author_sort | Johnson, Lawrence L. |
collection | PubMed |
description | Fibrin, a product of the blood coagulation cascade, accompanies many type 1 immune responses, including delayed-type hypersensitivity, autoimmunity, and graft rejection. In those settings, fibrin is thought to exacerbate inflammation and disease. Here, we evaluate roles for coagulation during infection with Toxoplasma gondii, a pathogen whose control requires robust type 1 immunity. We establish that fibrin prevents infection-stimulated blood loss, thereby performing a protective function that is essential for survival. Remarkably, fibrin does not simply protect against vascular damage caused directly by the infectious agent, but rather, protects against hemorrhage evoked by interferon-γ, a critical mediator of type 1 immunity. This finding, to our knowledge, is the first to document a beneficial role for coagulation during type 1 immunity, and suggests that fibrin deposition protects host tissue from collateral damage caused by the immune system as it combats infection. |
format | Text |
id | pubmed-2193855 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2003 |
publisher | The Rockefeller University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-21938552008-04-11 Fibrin-mediated Protection Against Infection-stimulated Immunopathology Johnson, Lawrence L. Berggren, Kiera N. Szaba, Frank M. Chen, Wangxue Smiley, Stephen T. J Exp Med Brief Definitive Report Fibrin, a product of the blood coagulation cascade, accompanies many type 1 immune responses, including delayed-type hypersensitivity, autoimmunity, and graft rejection. In those settings, fibrin is thought to exacerbate inflammation and disease. Here, we evaluate roles for coagulation during infection with Toxoplasma gondii, a pathogen whose control requires robust type 1 immunity. We establish that fibrin prevents infection-stimulated blood loss, thereby performing a protective function that is essential for survival. Remarkably, fibrin does not simply protect against vascular damage caused directly by the infectious agent, but rather, protects against hemorrhage evoked by interferon-γ, a critical mediator of type 1 immunity. This finding, to our knowledge, is the first to document a beneficial role for coagulation during type 1 immunity, and suggests that fibrin deposition protects host tissue from collateral damage caused by the immune system as it combats infection. The Rockefeller University Press 2003-03-17 /pmc/articles/PMC2193855/ /pubmed/12629066 http://dx.doi.org/10.1084/jem.20021493 Text en Copyright © 2003, The Rockefeller University Press This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see http://www.rupress.org/terms). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 4.0 Unported license, as described at http://creativecommons.org/licenses/by-nc-sa/4.0/). |
spellingShingle | Brief Definitive Report Johnson, Lawrence L. Berggren, Kiera N. Szaba, Frank M. Chen, Wangxue Smiley, Stephen T. Fibrin-mediated Protection Against Infection-stimulated Immunopathology |
title | Fibrin-mediated Protection Against Infection-stimulated Immunopathology |
title_full | Fibrin-mediated Protection Against Infection-stimulated Immunopathology |
title_fullStr | Fibrin-mediated Protection Against Infection-stimulated Immunopathology |
title_full_unstemmed | Fibrin-mediated Protection Against Infection-stimulated Immunopathology |
title_short | Fibrin-mediated Protection Against Infection-stimulated Immunopathology |
title_sort | fibrin-mediated protection against infection-stimulated immunopathology |
topic | Brief Definitive Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2193855/ https://www.ncbi.nlm.nih.gov/pubmed/12629066 http://dx.doi.org/10.1084/jem.20021493 |
work_keys_str_mv | AT johnsonlawrencel fibrinmediatedprotectionagainstinfectionstimulatedimmunopathology AT berggrenkieran fibrinmediatedprotectionagainstinfectionstimulatedimmunopathology AT szabafrankm fibrinmediatedprotectionagainstinfectionstimulatedimmunopathology AT chenwangxue fibrinmediatedprotectionagainstinfectionstimulatedimmunopathology AT smileystephent fibrinmediatedprotectionagainstinfectionstimulatedimmunopathology |